Discover Thomson Reuters
French drugmaker Sanofi said it still expected its COVID-19 vaccine to complete phase 3 trials in the first quarter, and reported a rise in fourth-quarter sales and earnings. Francis Maguire reports.
00:56
02:10
01:45
07:21
01:58
01:29
02:07
01:53
02:09
01:49
01:05
00:37
01:10
01:46
01:13
01:37
01:36
01:42
01:57